This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
GoHealth (GOCO.Q) Resumen de Acciones
GoHealth, Inc. opera como mercado de seguros médicos y empresa de salud digital centrada en Medicare en Estados Unidos. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 3/6 |
| Crecimiento futuro | 2/6 |
| Rendimiento pasado | 0/6 |
| Salud financiera | 1/6 |
| Dividendos | 0/6 |
Recompensas
Análisis de riesgos
+ 2 riesgos adicionales
GOCO.Q Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Competidores de GoHealth, Inc.
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$0.34 |
| Máximo en las últimas 52 semanas | US$6.61 |
| Mínimo de 52 semanas | US$0.27 |
| Beta | 1.23 |
| Cambio en 1 mes | -3.71% |
| Variación en 3 meses | -73.04% |
| Cambio de 1 año | -94.39% |
| Variación en 3 años | -98.11% |
| Variación en 5 años | -99.75% |
| Variación desde la OPV | -99.88% |
Noticias y actualizaciones recientes
Actualización de narrativa • Jul 17
GOCO.Q: Chapter 11 Restructuring Will Drive Future Upside After Nasdaq Delisting
Analysts have reduced their fair value estimate for GoHealth from $5.13 to $2.75 per share, citing updated assumptions around revenue growth, profitability, and a lower projected future P/E multiple. What’s in the News for GoHealth GoHealth and several affiliates filed voluntary petitions for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Delaware on June 7, 2026, with reported assets in the range of US$500 million to US$1b and liabilities in the range of US$1b to US$10b (Bankruptcy Filing).Actualización de narrativa • Jun 15
GOCO: Chapter 11 Reorganization Will Drive Future Upside Despite Imminent Delisting
Analysts have trimmed their price targets on GoHealth, citing slightly softer revenue growth assumptions and revised P/E outlooks following a recent downgrade highlighted in Street research. What's in the News GoHealth and certain subsidiaries filed voluntary Chapter 11 petitions in the US Bankruptcy Court for the District of Delaware on June 7, 2026, seeking reorganization with listed assets of $500 million to $1 billion and liabilities of $1 billion to $10 billion, according to court filings.Recent updates
Actualización de narrativa • Jul 17
GOCO.Q: Chapter 11 Restructuring Will Drive Future Upside After Nasdaq Delisting
Analysts have reduced their fair value estimate for GoHealth from $5.13 to $2.75 per share, citing updated assumptions around revenue growth, profitability, and a lower projected future P/E multiple. What’s in the News for GoHealth GoHealth and several affiliates filed voluntary petitions for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Delaware on June 7, 2026, with reported assets in the range of US$500 million to US$1b and liabilities in the range of US$1b to US$10b (Bankruptcy Filing).Actualización de narrativa • Jun 15
GOCO: Chapter 11 Reorganization Will Drive Future Upside Despite Imminent Delisting
Analysts have trimmed their price targets on GoHealth, citing slightly softer revenue growth assumptions and revised P/E outlooks following a recent downgrade highlighted in Street research. What's in the News GoHealth and certain subsidiaries filed voluntary Chapter 11 petitions in the US Bankruptcy Court for the District of Delaware on June 7, 2026, seeking reorganization with listed assets of $500 million to $1 billion and liabilities of $1 billion to $10 billion, according to court filings.Actualización de narrativa • Jun 01
GOCO: Higher Growth Assumptions Will Support Upside Despite Nasdaq Listing Risk
Analysts have adjusted their price target on GoHealth from $4.70 to $5.13, citing updated assumptions for revenue growth, profit margins, discount rate, and future P/E following recent research, including a downgrade at Freedom Broker. What's in the News GoHealth reported that it will be unable to file its next 10-Q with the SEC by the required deadline, citing a delayed SEC filing as of May 18, 2026.
Actualización de narrativa • Apr 30
GOCO: Lower P E And Improved Revenue Outlook Will Support Returns
Analysts have cut their 12 month price target for GoHealth by about $3, reflecting a reset in fair value assumptions along with updated views on revenue growth, margins and future P/E, following a recent downgrade highlighted in Street research. Analyst Commentary Bearish analysts are framing the latest downgrade as part of a broader reset in expectations for GoHealth, with the lower 12 month price target seen as a response to questions about how quickly the business can translate its model into consistent, scalable earnings.Actualización de narrativa • Apr 14
GOCO: Lower Earnings Multiple Will Support Upside Despite Nasdaq Compliance Risk
Analysts cut their GoHealth price target from $7.70 to $4.70 as they factor in updated assumptions for revenue growth and margins, and incorporate the recent downgrade at Freedom Broker into their outlook. Analyst Commentary Bullish Takeaways Bullish analysts view the reset to a US$4.70 target as a cleaner entry point that better reflects current expectations for revenue growth and margins, which they see as more achievable under updated assumptions.Actualización de narrativa • Mar 31
GOCO: Discount Rate Tweaks Will Support Upside Despite Nasdaq Compliance Risk
Analysts have nudged up their price target on GoHealth to $7.70, citing a slightly lower discount rate and modest tweaks to long term revenue growth, profit margin, and future P/E assumptions as key drivers of the change. What's in the News On March 18, 2026, GoHealth received a notice from Nasdaq that it is not in compliance with the minimum US$35 million market value of listed securities requirement under Listing Rule 5550(b)(2) (Nasdaq filing).Actualización de narrativa • Mar 17
GOCO: Stable Assumptions And Low Future P E Will Support Returns
Analysts have kept their GoHealth price target unchanged at $4.50. They point to only slight tweaks in revenue growth, profit margin and forward P/E assumptions that do not materially alter their overall view of the stock.Actualización de narrativa • Mar 03
GOCO: Stronger Margins And Lower P E Will Support Future Cash Flow
Analysts have trimmed their price target on GoHealth to reflect slightly weaker revenue expectations, a modestly stronger profit margin, and a marginally lower forward P/E. This results in a small downward adjustment in their $ price outlook for the stock.Actualización de narrativa • Feb 17
GOCO: Carrier Relationship Reset Will Support Future Cash Flow Recovery
Analysts have sharply reduced GoHealth's target, with one firm lowering its price target to $5 from $12 after Q3 results came in below expectations because of topline weakness tied to a suspended relationship with a large carrier. Analyst Commentary Bearish analysts are recalibrating their expectations after Q3 results came in well below what they were looking for, and the cut in the price target to $5 from $12 signals a more cautious stance on the stock.Actualización de narrativa • Feb 03
GOCO: Cash Burn Discipline And Carrier Reset Could Support Future Upside
Analysts have cut their price targets on GoHealth, including a reduction to US$5 from US$12. They cited weaker than expected Q3 results tied to topline softness from a suspended carrier relationship, a pullback in new enrollment growth, and ongoing concerns about market headwinds and cash flow sustainability.Actualización de narrativa • Jan 20
GOCO: Cash Discipline And Carrier Reset Will Support Future Cash Flow
Analysts have sharply reduced their GoHealth price targets, with one moving from US$12 to US$5. This reflects weaker Q3 results tied to a suspended carrier relationship, as well as concerns about ongoing market headwinds and cash flow visibility.Actualización de narrativa • Jan 06
GOCO: Focus On Cash Burn Discipline And Carrier Reset Supporting Future Stability
Narrative Update on GoHealth Analysts have cut their 12 month price target for GoHealth to US$5.00 from US$12.00, reflecting weaker Q3 results tied to a suspended relationship with a large carrier, softer revenue and Medicare submissions, a pullback in new enrollment growth, and concerns around ongoing market headwinds and uncertainty about achieving sustainable positive cash flow. Analyst Commentary Recent research updates on GoHealth reflect a cautious reset of expectations following Q3 results that came in below prior estimates, with price targets and ratings adjusted to reflect execution risks and a more uncertain growth outlook.Actualización de narrativa • Dec 15
GOCO: Cash Flow Improvements Will Outweigh Carrier Loss And Enrollment Pullback
Analysts have sharply reduced their price target on GoHealth from approximately $12.00 to about $5.00 per share. This reflects weaker than expected Q3 results, revenue headwinds from a suspended carrier relationship, and persistent concerns about the company's ability to deliver sustainable growth and cash flow in a challenging market.Actualización de narrativa • Dec 01
GOCO: Focus On Profitability And Cash Burn Reduction Will Drive Future Stability
Analysts have sharply reduced GoHealth's fair value estimate from $14 to $7.70 per share. They cite ongoing market headwinds, weaker-than-expected Q3 results, and challenges in revenue growth as key reasons for the downward revision.Actualización de narrativa • Nov 17
GOCO: Recent Credit Move Will Boost Flexibility Ahead of Enrollment Period
Analysts have revised GoHealth's fair value estimate downward from $17.20 to $14.00. This change is due to updated model assumptions and increased caution surrounding revenue growth following recent company results and financial transactions.Actualización de narrativa • Aug 25
Financial Flexibility And M&A Will Unlock Medicare And Senior Health Potential
GoHealth’s price target has been revised downward to $18.40, primarily reflecting reduced expectations for both future earnings multiples and revenue growth. What's in the News GoHealth has formed a Transformation Committee with new board members to evaluate strategic opportunities, including acquisitions, securitizations, and capital structure options.Actualización de narrativa • Aug 10
Financial Flexibility And M&A Will Unlock Medicare And Senior Health Potential
Despite higher revenue growth forecasts, GoHealth’s future P/E multiple has dropped sharply, indicating reduced investor confidence in earnings quality or sustainability, leading to a lower consensus price target of $19.60. What's in the News GoHealth has formed a Transformation Committee to evaluate acquisitions, financial structure options, securitizations, and other strategic opportunities for value creation.
Nueva narrativa • Mar 31
Medicare Engagement And Efficiency Will Drive Future Savings
GoHealth's shift to Medicare engagement enhances consumer relations and boosts operational efficiency, lowering costs and improving margins.Rentabilidad de los accionistas
| GOCO.Q | US Insurance | Mercado US | |
|---|---|---|---|
| 7D | -7.8% | -0.6% | -0.2% |
| 1Y | -94.4% | 2.8% | 11.9% |
Rentabilidad vs. Industria: Los resultados de GOCO.Q fueron inferiores a los de la industria US Insurance, que obtuvo un rendimiento del 2.8% el año pasado.
Rentabilidad vs. Mercado: GOCO.Q obtuvo unos resultados inferiores a los del mercado US, que fueron del 11.9% el año pasado.
Volatilidad de los precios
| GOCO.Q volatility | |
|---|---|
| GOCO.Q Average Weekly Movement | 19.0% |
| Insurance Industry Average Movement | 4.8% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 2.9% |
Precio estable de las acciones: El precio de las acciones de GOCO.Q ha sido volátil durante los últimos 3 meses en comparación con el mercado US.
Volatilidad a lo largo del tiempo: La volatilidad semanal de GOCO.Q ha aumentado de 14% a 19% en el último año.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2001 | 850 | Vijay Kotte | www.gohealth.com |
GoHealth, Inc. opera como mercado de seguros médicos y empresa de salud digital centrada en Medicare en Estados Unidos. La empresa ofrece planes de Medicare, incluidos planes Medicare Advantage, suplementos de Medicare, planes de medicamentos con receta y planes para necesidades especiales. También opera una plataforma tecnológica que aprovecha algoritmos de aprendizaje automático del comportamiento de compra de seguros para reimaginar el proceso de adecuación de un plan de salud a las necesidades específicas de un consumidor.
Resumen de fundamentos de GoHealth, Inc.
| Estadísticas fundamentales de GOCO.Q | |
|---|---|
| Capitalización bursátil | US$9.08m |
| Beneficios(TTM) | -US$293.88m |
| Ingresos (TTM) | US$152.79m |
0.0x
Ratio precio-ventas (PS)0.0x
Ratio precio-beneficio (PE)¿Está GOCO.Q sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de GOCO.Q | |
|---|---|
| Ingresos | US$152.79m |
| Coste de los ingresos | US$65.17m |
| Beneficio bruto | US$87.62m |
| Otros gastos | US$381.50m |
| Beneficios | -US$293.88m |
Últimos beneficios comunicados
Mar 31, 2026
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -17.61 |
| Margen bruto | 57.34% |
| Margen de beneficio neto | -192.35% |
| Ratio deuda/patrimonio | -949.5% |
¿Cómo se ha desempeñado GOCO.Q a largo plazo?
Ver rendimiento histórico y comparativaAnálisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/07/21 06:48 |
| Precio de las acciones al final del día | 2026/07/21 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
GoHealth, Inc. está cubierta por 13 analistas. 3 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Steven Valiquette | Barclays |
| Michael Cherny | BofA Global Research |
| Elizabeth Anderson | Evercore ISI |